International

International Session 03 - ASTRO-ESTRO Joint Session - Precision Radiation Oncology...Testing, Targeting, Treating

9/15/2019
4:45 PM - 6:00 PM
Location: Room W175

Session Type: International
1.25 AMA PRA Category 1 Credits™
1.50 MDCB Credits

Presentations:

Ben Slotman, MD, PhD, FASTRO

VU University Medical Center

Disclosure:
Employment
VU University Medical Center: Professor and Chair of Radiation Oncology: Employee

Compensation
Varian Medical Systems Inc: Research Grants: Travel Expenses;
ViewRay: Honoraria: Research Grants

Leadership
American Radium Society: Immediate Past President: Relationship ended 04/09/2019;
ESTRO: President-elect: 2018-2020; President-elect; Radiosurgery Society: Board Member

Biography:
Since 1998, Ben Slotman has served as Professor and Head of the Department of Radiation Oncology at Vrije Universiteit medical center (VUmc) in Amsterdam, The Netherlands. Dr. Slotman received his MD (1985) and PhD (1990) both with highest honor (cum laude) at VU University in Amsterdam, and he was registered as radiation oncologist in 1994. He also served as chairman of one of the six divisions of the VU academic center from 2006-2016. Since 2019, he is also chair of the other academic radiotherapy department in Amsterdam (AMC). Together, the academic centers form “Amsterdam university medical centers”.
Professor Slotman is the (co-)author of around 380 international peer-reviewed publications. His expertise lies mainly in the field of radiotherapy for lung and brain malignancies and the early clinical implementation of new technologies. He has (co-)organized various conferences and has coordinated a number of trials, including the EORTC study on prophylactic cranial irradiation in extensive stage small cell lung cancer (New Engl J Med 2007) and the international randomized trial on the role of thoracic irradiation in these patients (The Lancet 2017). His research activities are further concentrated on intra- and extracranial stereotactic radiotherapy and the introduction of various new technologies in radiotherapy, most recently being stereotactic MRI-guided adaptive radiotherapy.
He was awarded as an honorary fellow of the American College of Radiology in May 2017 and received the Jacob Fabrikant award of ISRS in June 2017. He was awarded FASTRO in 2018. He was president of the American Radium Society (2017-18), member of the Board of ISRS (2013-2017) and is on the Board of directors of the Radiosurgery Society since 2016. Since 2018, he is president-elect of ESTRO.

Presentation(s):

Send Email for Ben Slotman

Paul Harari, MD, FASTRO

University of Wisconsin Hospitals and Clinics

Disclosure:
Employment
University of Wisconsin: Professor and Chairman: Employee

Biography:
As professor and chairman of the UW Department of Human Oncology, principal investigator for the Wisconsin H&N SPORE Grant and member of the UW Carbone Cancer Center Senior Leadership Council, I facilitate the interaction of investigators involved in basic, translational and clinical cancer research activities. I'm committed to the leadership of multidisciplinary clinical, teaching and research teams.

The overall theme of my clinical and laboratory research is to improve treatment outcome for patients with head and neck cancer (HNC). Areas of particular research emphasis include the interaction of molecular growth inhibitors combined with radiation and the use of conformal radiation treatment techniques to limit normal tissue toxicity. I serve as PI for a recently funded SPORE Grant in HNC at the University of Wisconsin and direct one scientific project as well as the Administrative Core within the SPORE Grant. I have previously served as PI for NIH R29 and R01 laboratory research grants investigating HNC response and resistance mechanisms in combination with radiation. I have been an active RTOG HNC Committee member for more than 20 years (now NRG) and serve as PI or co-PI for a series of national and international HNC trials.

Serving currently as president of ASTRO, a focus is to illuminate the power and precision of radiation to heal, to cure, to image, to improve human health and quality of life. We convey this message most through storytelling, the passionate stories of patients and families whose lives have been saved or extended by the expert application of radiation. A unique and highly appealing aspect of radiation oncology is the opportunity for close collaboration between technology, biology and clinical medicine. Never have the prospects for impactful advances in our field been so bright, and many of these advances involve multi-investigator teams, working together to achieve new milestones.

Presentation(s):

Send Email for Paul Harari


Assets

International Session 03 - ASTRO-ESTRO Joint Session - Precision Radiation Oncology...Testing, Targeting, Treating



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for International Session 03 - ASTRO-ESTRO Joint Session - Precision Radiation Oncology...Testing, Targeting, Treating